Neil Kumar is Chief Executive Officer of BridgeBio Pharma, Inc.. Currently has a direct ownership of 223,090 shares of BBIO, which is worth approximately $11.4 Million. The most recent transaction as insider was on Nov 16, 2020, when has been sold 1,774 shares (Common Stock) at a price of $44.33 per share, resulting in proceeds of $78,641. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 223K
2.62% 3M change
95.44% 12M change
Total Value Held $11.4 Million

Neil Kumar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2020
SELL
Payment of exercise price or tax liability
$78,641 $44.33 p/Share
1,774 Reduced 0.04%
4,692,435 Common Stock
Nov 16 2020
BUY
Exercise of conversion of derivative security
-
5,129 Added 0.11%
4,694,209 Common Stock
NK

Neil Kumar

Chief Executive Officer
Palo Alto, CA

Track Institutional and Insider Activities on BBIO

Follow BridgeBio Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO